Healthcare provider profile · identity verified

Daryl Ellis, MD

Allopathic & Osteopathic Physicians|Family Medicine · PHENIX CITY, AL · NPI 1467468355

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daryl Ellis, MD received $66.94 in general payments during 2025 across 3 reported records.

Verona Pharma, Inc. accounted for 37.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Farxiga by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 202 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$66.94

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Verona Pharma, Inc.	Unresolved — no canonical attribution shown	$25.34	37.9%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$22.37	33.4%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$19.23	28.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$66.94	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ohtuvayre Normalized: ohtuvayre	Drug	Verona Pharma, Inc.	$25.34	1	2025
Source payment records 2025-12-08 · Verona Pharma, Inc. · $25.34 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$22.37	1	2025
Source payment records 2025-09-24 · Novo Nordisk Inc · $22.37 · Open Payments source
AIRSUPRA Normalized: airsupra	Drug	AstraZeneca Pharmaceuticals LP	$19.23	1	2025
Source payment records 2025-10-08 · AstraZeneca Pharmaceuticals LP · $19.23 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	38	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	202	53
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1008	306
Amlodipine Besylate	Amlodipine Besylate	804	251
Fluticasone Propionate	Fluticasone Propionate	349	133
Metformin Hcl	Metformin Hcl	347	113
Levothyroxine Sodium	Levothyroxine Sodium	343	105
Omeprazole	Omeprazole	342	110
Losartan Potassium	Losartan Potassium	339	105
Hydrochlorothiazide	Hydrochlorothiazide	308	98
Lisinopril	Lisinopril	308	97
Pantoprazole Sodium	Pantoprazole Sodium	281	104
Gabapentin	Gabapentin	267	88
Potassium Chloride	Potassium Chloride	254	102
Albuterol Sulfate Hfa	Albuterol Sulfate	224	75
Rosuvastatin Calcium	Rosuvastatin Calcium	216	72
Ozempic	Semaglutide	202	53
Metoprolol Succinate	Metoprolol Succinate	200	65
Furosemide	Furosemide	192	68
Carvedilol	Carvedilol	190	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	170	41
Meloxicam	Meloxicam	167	50
Tramadol Hcl	Tramadol Hcl	166	62
Trazodone Hcl	Trazodone Hcl	146	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	144	44
Tamsulosin Hcl	Tamsulosin Hcl	137	42
Allopurinol	Allopurinol	128	47
Metoprolol Tartrate	Metoprolol Tartrate	120	38
Clopidogrel	Clopidogrel Bisulfate	116	39
Glimepiride	Glimepiride	114	31
Prednisone	Prednisone	114	76
Atenolol	Atenolol	113	32
Ezetimibe	Ezetimibe	109	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	107	39
Simvastatin	Simvastatin	107	31
Tizanidine Hcl	Tizanidine Hcl	105	47
Chlorthalidone	Chlorthalidone	102	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	101	34
Alprazolam	Alprazolam	100	28
Hydralazine Hcl	Hydralazine Hcl	99	32
Celecoxib	Celecoxib	98	40
Eliquis	Apixaban	97	32
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	97	40
Metformin Hcl Er	Metformin Hcl	97	35
Pravastatin Sodium	Pravastatin Sodium	94	27
Donepezil Hcl	Donepezil Hcl	92	31
Montelukast Sodium	Montelukast Sodium	92	26
Pioglitazone Hcl	Pioglitazone Hcl	92	23
Famotidine	Famotidine	90	34
Ibuprofen	Ibuprofen	86	38
Trulicity	Dulaglutide	84	21
Sertraline Hcl	Sertraline Hcl	82	26
Clonazepam	Clonazepam	77	18
Januvia	Sitagliptin Phosphate	75	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	29
Hydroxyzine Hcl	Hydroxyzine Hcl	73	24
Temazepam	Temazepam	72	19
Zolpidem Tartrate	Zolpidem Tartrate	72	16
Fluoxetine Hcl	Fluoxetine Hcl	71	26
Spironolactone	Spironolactone	69	22
Nifedipine Er	Nifedipine	68	24
Diclofenac Sodium	Diclofenac Sodium	65	23
Duloxetine Hcl	Duloxetine Hcl	61	18
Escitalopram Oxalate	Escitalopram Oxalate	61	20
Methylprednisolone	Methylprednisolone	61	45
Alendronate Sodium	Alendronate Sodium	60	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	60	29
Meclizine Hcl	Meclizine Hcl	59	20
Mounjaro	Tirzepatide	59	13
Linzess	Linaclotide	57	23
Citalopram Hbr	Citalopram Hydrobromide	56	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	19
Pregabalin	Pregabalin	53	21
Azithromycin	Azithromycin	52	45
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	16
Ondansetron Odt	Ondansetron	50	26
Telmisartan	Telmisartan	50	14
Humalog Kwikpen U-100	Insulin Lispro	49	13
Buspirone Hcl	Buspirone Hcl	48	17
Naproxen	Naproxen	48	27
Lorazepam	Lorazepam	46	suppressed
Novolog Flexpen	Insulin Aspart	45	13
Ropinirole Hcl	Ropinirole Hcl	45	14
Estradiol	Estradiol	44	12
Fenofibrate	Fenofibrate	44	14
Bupropion Hcl Sr	Bupropion Hcl	43	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	11
Levetiracetam	Levetiracetam	41	14
Topiramate	Topiramate	41	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	21
Triamcinolone Acetonide	Triamcinolone Acetonide	40	26
Valacyclovir	Valacyclovir Hcl	40	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	33
Baclofen	Baclofen	39	11
Breo Ellipta	Fluticasone/Vilanterol	39	13
Clonidine Hcl	Clonidine Hcl	38	13
Farxiga	Dapagliflozin Propanediol	38	suppressed
Finasteride	Finasteride	38	12
Jardiance	Empagliflozin	38	14
Paroxetine Hcl	Paroxetine Hcl	38	14
Lamotrigine	Lamotrigine	37	11
Xarelto	Rivaroxaban	37	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	13
Gemfibrozil	Gemfibrozil	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	11
Fluconazole	Fluconazole	33	14
Glipizide	Glipizide	32	suppressed
Verapamil Er	Verapamil Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	11
Diazepam	Diazepam	30	suppressed
Metolazone	Metolazone	30	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	11
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Liothyronine Sodium	Liothyronine Sodium	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	22
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Myrbetriq	Mirabegron	27	12
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Rybelsus	Semaglutide	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Megestrol Acetate	Megestrol Acetate	24	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	20
Nitroglycerin	Nitroglycerin	24	14
Sucralfate	Sucralfate	24	suppressed
Valsartan	Valsartan	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Levofloxacin	Levofloxacin	20	19
Phenobarbital	Phenobarbital	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	11
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Tramadol Hcl Er	Tramadol Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Ketoconazole	Ketoconazole	18	suppressed
Pentoxifylline	Pentoxifylline	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Colchicine	Colchicine	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Rexulti	Brexpiprazole	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Levemir Flextouch	Insulin Detemir	13	suppressed
Nystatin	Nystatin	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Indapamide	Indapamide	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$66.94 · 3 records	Verona Pharma, Inc.	AIRSUPRA, Ohtuvayre, Wegovy	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error